Yasushi Miyazaki Selected Research

Yasushi Miyazaki Research Topics

Disease

31	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2003
26	Neoplasms (Cancer) 02/2022 - 10/2002
26	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2022 - 08/2010
25	Leukemia 11/2021 - 09/2004
24	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 09/2004
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2006
14	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021 - 02/2007
11	Philadelphia Chromosome 01/2022 - 02/2008
7	Febrile Neutropenia 01/2022 - 07/2011
7	Infections 09/2020 - 11/2006
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2012
6	Acute Promyelocytic Leukemia 12/2020 - 03/2007
5	Thrombocytopenia (Thrombopenia) 05/2022 - 10/2003
5	Neutropenia 05/2022 - 07/2011
5	Lymphoma (Lymphomas) 10/2020 - 03/2004
5	Pathologic Complete Response 02/2016 - 01/2006
4	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 01/2019
4	Disease Progression 08/2021 - 03/2004
4	Bronchiolitis Obliterans Syndrome 01/2019 - 01/2018
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2022 - 02/2016
3	Residual Neoplasm 01/2022 - 11/2008
3	Pneumonia (Pneumonitis) 08/2021 - 03/2007
3	Hemorrhage 12/2020 - 03/2007
3	Chromosome Aberrations (Chromosome Abnormalities) 02/2020 - 01/2003
2	Erythema 01/2022 - 01/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2019
2	Mycosis Fungoides 01/2022 - 12/2008
2	Candidiasis (Moniliasis) 08/2021 - 06/2015
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 03/2021 - 07/2007
2	Hodgkin Disease (Hodgkin's Disease) 03/2021 - 01/2017
2	Leukocytosis (Pleocytosis) 12/2020 - 10/2003
2	Wilms Tumor (Wilm's Tumor) 10/2020 - 01/2016
2	Adenocarcinoma 10/2020 - 06/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 08/2014
2	Invasive Pulmonary Aspergillosis 01/2020 - 12/2018
2	Dyspnea (Shortness of Breath) 01/2020 - 01/2019
2	Lymphadenopathy 04/2019 - 01/2017
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019 - 02/2004
2	Multiple Myeloma 01/2019 - 08/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 01/2017
2	Fever (Fevers) 11/2017 - 11/2006
2	Primary Myelofibrosis (Myelosclerosis) 11/2016 - 01/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2016 - 11/2006
2	Carcinogenesis 12/2014 - 05/2011

Drug/Important Bio-Agent (IBA)

19	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2006
8	Azacitidine (5 Azacytidine)FDA Link 08/2022 - 10/2014
6	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2022 - 03/2010
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2020 - 03/2007
6	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2002
5	Tyrosine Kinase InhibitorsIBA 11/2021 - 04/2012
4	Pharmaceutical PreparationsIBA 05/2022 - 10/2003
4	SteroidsIBA 01/2022 - 01/2018
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 11/2014
4	mogamulizumabIBA 10/2020 - 04/2015
4	Transcription Factors (Transcription Factor)IBA 07/2020 - 02/2011
3	Phosphotransferases (Kinase)IBA 05/2022 - 01/2014
3	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 10/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 10/2010
3	LigandsIBA 12/2020 - 01/2016
3	Biological ProductsIBA 10/2020 - 01/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2020 - 11/2017
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2020 - 09/2015
3	Lenalidomide (CC 5013)FDA Link 04/2020 - 08/2014
3	Immunoglobulin G (IgG)IBA 01/2019 - 11/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2004
3	Messenger RNA (mRNA)IBA 01/2016 - 03/2013
2	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2022 - 02/2011
2	BI 6727IBA 05/2022 - 11/2015
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2022 - 12/2014
2	venetoclaxIBA 01/2022 - 08/2021
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 04/2009
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2017
2	Etoposide (VP 16)FDA LinkGeneric 03/2021 - 11/2014
2	Peptides (Polypeptides)IBA 10/2020 - 12/2017
2	Mucin-1 (CA 15-3 Antigen)IBA 10/2020 - 06/2011
2	FluoroquinolonesIBA 09/2020 - 12/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 08/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2019 - 01/2019
2	Ferritins (Ferritin)IBA 11/2019 - 09/2012
2	IronIBA 11/2019 - 07/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2019 - 12/2013
2	AntigensIBA 01/2019 - 12/2018
2	tamibaroteneIBA 01/2019 - 11/2014
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 09/2006
2	Creatine Kinase (Creatine Phosphokinase)IBA 12/2017 - 02/2007
2	Inosine Triphosphate (ITP)IBA 02/2016 - 11/2006

Therapy/Procedure

40	Therapeutics 10/2022 - 09/2004
30	Hematopoietic Stem Cell Transplantation 10/2022 - 02/2004
30	Drug Therapy (Chemotherapy) 08/2022 - 10/2003
16	Transplantation 01/2022 - 03/2004
7	Remission Induction 12/2020 - 01/2006
7	Cell Transplantation 01/2020 - 03/2012
7	Stem Cell Transplantation 01/2020 - 02/2004
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 03/2004
3	Induction Chemotherapy 09/2020 - 03/2010
3	Radiotherapy 01/2019 - 01/2017
2	Liver Transplantation 10/2020 - 01/2019
2	Activities of Daily Living (ADL) 01/2019 - 09/2004
2	Consolidation Chemotherapy 12/2018 - 02/2011
2	Salvage Therapy 08/2018 - 12/2013